SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ICN Pharmaceuticals
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Clouseau who wrote (950)12/9/1998 9:25:00 PM
From: Robert Florin  Read Replies (1) of 1029
 
They all deserted you for the highly contentious, anonymous Yahoo bbs. I actually wish a rational dialogue about ICN returned to SI because the people are more responsible about their posts, and civil.

Another interesting announcement is the use of drugs which sensitize wbc's to light and reduce their antibody rejection. There could be an interesting use of a boring pharmaceutical, and have much wider application than just heart transplant rejection. However, I think that the announcement was expected and that after an initial opening rally, the stock will settle back and trade in this range until insiders know that the company has turned the earnings corner. My guess is that you will know that by persistent buying pushing the stock past 30. Could be a quarter or more away.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News